Print
Entrepreneurs

Tapping Synthetic CBD For Pain Relief

By Jenny Callison, posted Jul 17, 2020
BIOTECH | ISOSCELES PHARMACEUTICALS INC. BRETT LANIER, PRESIDENT | YEAR FOUNDED: 2019 | EMPLOYEES: 7 (Photo by Terah Wilson)
Early-stage venture Isosceles Pharmaceuticals is working on developing non-opioid pain relief alternatives to opium-derived drugs such as Oxycodone. Working with a group of medical doctors and pharmaceutical Ph.D.s, the young company wants to formulate products that will be effective in treating post-operative acute pain safely, using synthetic cannabidiol manufactured under an FDA drug master file.
 
Patients would be administered the drug intravenously or through a skin patch.
 
“Our cannabidiol, or CBD, is created in a laboratory under lab conditions, so it’s synthetic and not hemp derived,” said founder and President Brett Lanier, a medicinal chemist with more than a decade of experience in the pharmaceutical industry. “As a comparison, aspirin originally came from the bark of willow trees, but we no longer grow willow trees to make aspirin; we synthesize it. There are too many impurities in an agricultural product; the FDA would not approve it.”
 
“Isosceles has a team of medical doctors and pharmaceutical Ph.D.s with a proven track record of drug development and FDA approval for pain products and transdermal pain patches,” the company’s nomination form stated. “They have a combined 130 years of pharmaceutical experience and multiple FDA drug approvals. Isosceles is leveraging that experience to develop a completely new type of pain product through the clinical trial process.”
 
There is a large market for non-opioid drugs that address acute, post-operative pain, Lanier said.
 
If the venture is successful, its products would aim to reduce the amount of opioids prescribed after surgery, and, Lanier noted, could reduce pediatric exposure to opioids.
 
He believes that CBD’s strong endorsement from the FDA means that Isosceles’ products will be approved for use with children as well as adults.
 
“Research shows that children initially got exposed to opioids through dental surgery, such as extraction of wisdom teeth,” he said.
 
Isosceles Pharmaceuticals has received some early-stage funding, according to Lanier. In May, the company was the winner of the inaugural NC BIONEER Venture Challenge, a competition aimed at enhancing life sciences and biotechnology business ventures in the region.
 
Its award consisted of a $20,000 investment and a one-year tenancy at the University of North Carolina Wilmington’s Center for Innovation and Entrepreneurship.
 
“Isosceles Pharmaceuticals is fortunate to have the crucial mix of a great idea that meets an existing market need, a strong team headed by an exceptional entrepreneurial leader, an impressive rollout and growth plan and attractiveness for raising equity capital,” said Randall Johnson, executive director of the N.C. Biotechnology Center Southeastern Office in Wilmington. “Brett Lanier possesses a flexible, go-getter attitude and unceasing drive that bode well for the success of the venture and were on full display when he recently participated in and won the NC BIONEER Venture Challenge.”

Meet all of this year's CEA winners

Ico insights

INSIGHTS

SPONSORS' CONTENT
Screenshot2022 01 06at338 162234623

Food is the Foundation for Prosperous Communities

Girard Newkirk - Genesis Block
Burrus rob headshot 300x300

Spreading Wings for Flight: 2nd Annual Trade Show Highlights the Ingenuity of UNCW Business Students

Robert Burrus - Cameron School of Business - UNC-Wilmington
Untitleddesign7

Getting Your Community Ready for Spring and Summer

Dave Orr - Community Association Management Services

Trending News

Conservation Group Signs $8M Deal To Buy The Point On Topsail Island

Audrey Elsberry - Mar 26, 2024

Rezoning Could Bring 123 Townhomes To Growing Leland Corridor

Emma Dill - Mar 25, 2024

N.C. Ports Officials React To Baltimore Bridge Collapse

Audrey Elsberry - Mar 26, 2024

Engineering Firm Hires Four Employees

Staff Reports - Mar 26, 2024

National Organization Bestows Top Award On Cape Fear Professional Women In Building

Staff Reports - Mar 26, 2024

In The Current Issue

INFO JUNKIE: Jack Fleming

Jack Fleming, owner of Socialry Marketing & Scourz and emcee for 1 Million Cups Wilmington, shares his media and tech picks....


MADE: Polyhose Inc.

Polyhose manufactures and fabricates hose protection, paint hose assemblies and rubber hydraulic assemblies from its Pender County facility....


Expanding Tastes On Castle Street

As John Willse and Beth Guertin, owners of Wilmington Wine bottle shop and now the recently opened Creative Tastings restaurant on Castle St...

Book On Business

The 2024 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

2023 Power Breakfast: Major Developments